HomeNewsBusinessInvestors await RBI measures for bond market after government raises borrowing: Report

Investors await RBI measures for bond market after government raises borrowing: Report

Investors are looking at the Reserve Bank of India (RBI) to announce open market operations (OMOs) worth Rs 2.5-3 lakh crore, to restore demand for government bonds

May 12, 2020 / 15:40 IST
Story continues below Advertisement
Representative image
Representative image

The cost of funding rose after the Centre said on May 11 that it had increased borrowing for FY21 to Rs 12 lakh crore – a 50 percent hike compared to FY20, and up from the Rs 7.8 lakh crore budgeted in February. The increase is to tackle liquidity concerns arising from the coronavirus pandemic.

There are concerns of oversupply of bonds in the market, due to which both sovereign and corporate bonds rose by 20 basis points, The Economic Times reported. (1 bps = 0.01 percentage point)

Story continues below Advertisement

In lieu of this, investors are looking at the Reserve Bank of India (RBI) to announce open market operations (OMOs) worth Rs 2.5-3 lakh crore to restore demand for government bonds.

Naveen Singh, the head of trading at ICICI Securities Primary Dealership, told the paper that the borrowing rise was expected, but “not so early.”

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show